_61A6728

Cellular products

In cellular therapy (CT), human cells are used to replace or repair damaged tissue and/or cells. CT is therefore at the forefront of regenerative medicine, enabling scientists to discover new ways to halt and reverse different diseases and provide cures for many life-threatening conditions.

Know what you need?

Fill in our contact us form below, and we’ll aim to get back to you within one working day.

In cellular therapy (CT), human cells are used to replace or repair damaged tissue and/or cells. CT is therefore at the forefront of regenerative medicine, enabling scientists to discover new ways to halt and reverse different diseases and provide cures for many life-threatening conditions.

Anthony Nolan is one of the world’s foremost authorities on the sourcing and supply of raw starting materials for the sector.  We have a register of over 890,000 donors, a comprehensive cord blood bank of over 10,000 clinical grade units, a ground-breaking Cell Therapy centre, and four decades of experience providing stem cells. Read on to see how our infrastructure, expertise, and skills can support your work within the cell and gene therapy industry.

Have a specific question, that’s not covered here, or looking for quick answers?
Fill in our contact us form and we’ll aim to get back to you within one working day.

Quality starting materials

Specialising in cell sourcing, collection, processing and immunotherapy research and development (R&D), we deliver high-quality starting materials to match and meet your specifications and standards. By choosing us as your partner, you have the reassurance that:

  • Our donor register is accredited by the World Marrow Donor Association (WMDA) and we are licenced by the Human Tissue Authority (HTA)
  • Our Cell Therapy Centre holds National Ethical Approval and FACT-NetCord accreditation
  • We have achieved Research Tissue Bank (RTB) status, allowing us to collect, store and release adult and cord material.

All applications for material are reviewed by the Anthony Nolan Independent Review Board (IRB), who ensure we facilitate ethical R&D in a robust and transparent manner and approve applications based on their research ethics.

State-of-the-art facilities

The Anthony Nolan Cell Therapy Centre was opened in 2008 by the UK Secretary of State for Health in the grounds of Nottingham Trent University.  It specialises in the processing, testing and storage of human cells for both human and research applications.  

Established with the help of the James Tudor Foundation and the East Midlands Development Agency, the facility houses both C and D grade clean rooms and an extensive cryogenic storage area as well as a suite of cutting-edge equipment including:   

  • Cytiva Sepax automated cell processing system  
  • Cytiva Smartmax  
  • Asymptote VIA Freeze  
  • Planer LN2 Controlled rate freezer    
  • Miltenyi CliniMacs Plus Cell isolation system  
  • Miltenyi MacsQuant Tyto Cell Sorter
  • Miltenyi Tissue Dissociator   
  • Large Freestanding centrifuge (suitable for blood bags)  
  • BD FACS Canto II  
  • Sysmex XE2100  
  • Nucleocounter NC-202
  • Temp and CO2 controlled Incubators  
  • Bactec FX automated blood culture analyser 

Expertise you can rely on

Anthony Nolan’s Cell and Gene Therapy Services help researchers and developers advance medical understanding in cell and gene therapy by sourcing and supplying donor starting materials. 

We are leaders in our field, dedicated to conducting and helping facilitate world-class, lifesaving research. We think of our clients as partners. They come back to us again and again, knowing we’ll provide the utmost in quality and reliability.  

With a staff of seasoned clinicians and researchers, and a laser-focused business delivery team, we can provide you with the scientific and commercial support you need to achieve your R&D goals. 

However complex or unique your request, contact us and our team of experts will ensure we deliver the right materials on time and on budget to help you advance your therapeutic pipeline.